SCHEMBL1818962

SCHEMBL1818962

Cc1cccc(C(=O)O)c1Nc1c(Br)c(C)nn1-c1cccc(F)c1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 12/20 0.42
KDM4E B2RXH2 2/20 0.40
POLB P06746 1/20 0.39
SCN9A Q15858 1/20 0.38
TSHR P16473 1/20 0.37
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
AKR1B10 O60218 1/20 0.36
TRPA1 O75762 1/20 0.36
ABCB11 O95342 1/20 0.36
DHFR P00374 1/20 0.36
LMNA P02545 1/20 0.36
MPO P05164 1/20 0.36
CYP1A2 P05177 1/20 0.36
CHRM1 P11229 1/20 0.36
AKR1B1 P15121 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1817001 0.89 ADORA1 (0.48) ADORA1POLBTSHRCYP3A4CYP2C9
SCHEMBL1815547 0.88 KDM4E (0.42) ADORA1KDM4EPOLBTSHRCYP3A4
SCHEMBL1814786 0.87 KDM4E (0.42) ADORA1KDM4ECYP3A4CYP2C9ALDH1A1
SCHEMBL1810125 0.87 KDM4E (0.42) ADORA1KDM4EPOLBKMT2ADHODH
SCHEMBL1811983 0.85 ADORA1 (0.44) ADORA1KDM4EPOLBKMT2AADORA2B
SCHEMBL1814347 0.85 TAS2R14 (0.45) ADORA1POLBTSHRADORA2BDHODH
SCHEMBL1817101 0.83 SMN1; SMN2 (0.47) KDM4EPOLBCYP3A4CYP2C9KMT2A
SCHEMBL1809503 0.83 ADORA1 (0.43) ADORA1KDM4EPOLBALDH1A1HPGD
SCHEMBL1818960 0.79 KMT2A (0.42) ADORA1KDM4EPOLBKMT2ACYP1A2
SCHEMBL1814089 0.78 MAPT (0.44) ADORA1KDM4EPOLBTSHRKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321296-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2011-05-18 EP disclosed
US-20100099681-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-22 US disclosed
WO-2010020363-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099681-A1 SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF CYP3A5, ABAT, TPMT ADORA1 724/4885KDM4E 2516/4885POLB 2263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.